Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein transport protein Sec61 subunit alpha (Sec61α) is the primary pore-forming subunit of the heterotrimeric Sec61 translocon complex, which is essential for protein biogenesis in the endoplasmic reticulum (ER) [1, 3]. It facilitates the translocation of nascent polypeptides into the ER lumen and the integration of transmembrane proteins into the lipid bilayer, a process critical for roughly one-third of the human proteome [15, 16]. In addition to its transport function, Sec61α acts as a passive calcium leak channel and a ribosome receptor, playing a key role in maintaining cellular calcium homeostasis and regulating the unfolded protein response [4, 6]. Genetic mutations in SEC61A1 lead to "Sec61-channelopathies," manifesting as kidney disease, neutropenia, or immunodeficiency [1, 12]. Pharmacologically, Sec61α is an emerging target for cancer therapy; small-molecule inhibitors like KZR-261 can selectively block the translocation of specific "client" proteins, such as oncogenic growth factors, thereby inducing ER stress and cell death [6, 8]. Furthermore, Sec61α inhibitors exhibit potent antiviral properties by disrupting the production of viral envelope glycoproteins required for the assembly of viruses like SARS-CoV-2 and Ebola [4, 7].
Inhibition of protein translocation into the endoplasmic reticulum by stabilizing the translocon in a closed state or blocking signal peptide recognition, leading to ER stress and apoptosis.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein transport protein Sec61 subunit alpha (SEC61A1).